Primed in situ labeling for rapid prenatal diagnosis

G. V.N. Velagelati, L. P. Shulman, O. P. Phillips, S. A. Tharapel, A. T. Tharapel, M. Johnson, P. Tomich, N. Ginsburg

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

OBJECTIVE: Our purpose was to assess the feasibility of primed in situ labeling for analysis of prenatal diagnostic specimens. STUDY DESIGN: Prenatal diagnostic specimens were chosen at random for analysis without knowledge of clinical indication. Primed in situ labeling with primers for chromosomes 18, 21, X, and Y was performed separate from conventional cytogenetic analyses. All clinical management considerations were based solely on conventional cytogenetic analyses. RESULTS: Forty-one samples were analyzed by primed in situ labeling: 35 direct preparations of chorionic villi and 6 uncultured amniotic fluid samples. In all cases analysis confirmed the particular chromosome number determined by conventional cytogenetic analysis. CONCLUSIONS: Although conventional metaphase studies remain the standard for prenatal cytogenetic analyses, the preliminary feasibility study finds primed in situ labeling to be a rapid and reliable adjunctive diagnostic technique applicable for prenatal diagnosis in certain clinical situations. Further study is needed to assess the efficacy of primed in situ labeling in comparison to fluorescent in situ hybridization and conventional cytogenetic analyses for prenatal diagnoses.

Original languageEnglish (US)
Pages (from-to)1313-1320
Number of pages8
JournalAmerican Journal of Obstetrics and Gynecology
Volume178
Issue number6
DOIs
StatePublished - Jan 1 1998

Fingerprint

Primed In Situ Labeling
Cytogenetic Analysis
Prenatal Diagnosis
Chromosomes, Human, Pair 18
Chorionic Villi
Chromosomes, Human, Pair 21
Feasibility Studies
Amniotic Fluid
Metaphase
Fluorescence In Situ Hybridization
Chromosomes

Keywords

  • Cytogenetics
  • In situ hybridization
  • Prenatal diagnosis

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Velagelati, G. V. N., Shulman, L. P., Phillips, O. P., Tharapel, S. A., Tharapel, A. T., Johnson, M., ... Ginsburg, N. (1998). Primed in situ labeling for rapid prenatal diagnosis. American Journal of Obstetrics and Gynecology, 178(6), 1313-1320. https://doi.org/10.1016/S0002-9378(98)70338-2

Primed in situ labeling for rapid prenatal diagnosis. / Velagelati, G. V.N.; Shulman, L. P.; Phillips, O. P.; Tharapel, S. A.; Tharapel, A. T.; Johnson, M.; Tomich, P.; Ginsburg, N.

In: American Journal of Obstetrics and Gynecology, Vol. 178, No. 6, 01.01.1998, p. 1313-1320.

Research output: Contribution to journalArticle

Velagelati, GVN, Shulman, LP, Phillips, OP, Tharapel, SA, Tharapel, AT, Johnson, M, Tomich, P & Ginsburg, N 1998, 'Primed in situ labeling for rapid prenatal diagnosis', American Journal of Obstetrics and Gynecology, vol. 178, no. 6, pp. 1313-1320. https://doi.org/10.1016/S0002-9378(98)70338-2
Velagelati GVN, Shulman LP, Phillips OP, Tharapel SA, Tharapel AT, Johnson M et al. Primed in situ labeling for rapid prenatal diagnosis. American Journal of Obstetrics and Gynecology. 1998 Jan 1;178(6):1313-1320. https://doi.org/10.1016/S0002-9378(98)70338-2
Velagelati, G. V.N. ; Shulman, L. P. ; Phillips, O. P. ; Tharapel, S. A. ; Tharapel, A. T. ; Johnson, M. ; Tomich, P. ; Ginsburg, N. / Primed in situ labeling for rapid prenatal diagnosis. In: American Journal of Obstetrics and Gynecology. 1998 ; Vol. 178, No. 6. pp. 1313-1320.
@article{190d085fa0014cfaa1b8c772f3e0e4d7,
title = "Primed in situ labeling for rapid prenatal diagnosis",
abstract = "OBJECTIVE: Our purpose was to assess the feasibility of primed in situ labeling for analysis of prenatal diagnostic specimens. STUDY DESIGN: Prenatal diagnostic specimens were chosen at random for analysis without knowledge of clinical indication. Primed in situ labeling with primers for chromosomes 18, 21, X, and Y was performed separate from conventional cytogenetic analyses. All clinical management considerations were based solely on conventional cytogenetic analyses. RESULTS: Forty-one samples were analyzed by primed in situ labeling: 35 direct preparations of chorionic villi and 6 uncultured amniotic fluid samples. In all cases analysis confirmed the particular chromosome number determined by conventional cytogenetic analysis. CONCLUSIONS: Although conventional metaphase studies remain the standard for prenatal cytogenetic analyses, the preliminary feasibility study finds primed in situ labeling to be a rapid and reliable adjunctive diagnostic technique applicable for prenatal diagnosis in certain clinical situations. Further study is needed to assess the efficacy of primed in situ labeling in comparison to fluorescent in situ hybridization and conventional cytogenetic analyses for prenatal diagnoses.",
keywords = "Cytogenetics, In situ hybridization, Prenatal diagnosis",
author = "Velagelati, {G. V.N.} and Shulman, {L. P.} and Phillips, {O. P.} and Tharapel, {S. A.} and Tharapel, {A. T.} and M. Johnson and P. Tomich and N. Ginsburg",
year = "1998",
month = "1",
day = "1",
doi = "10.1016/S0002-9378(98)70338-2",
language = "English (US)",
volume = "178",
pages = "1313--1320",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "6",

}

TY - JOUR

T1 - Primed in situ labeling for rapid prenatal diagnosis

AU - Velagelati, G. V.N.

AU - Shulman, L. P.

AU - Phillips, O. P.

AU - Tharapel, S. A.

AU - Tharapel, A. T.

AU - Johnson, M.

AU - Tomich, P.

AU - Ginsburg, N.

PY - 1998/1/1

Y1 - 1998/1/1

N2 - OBJECTIVE: Our purpose was to assess the feasibility of primed in situ labeling for analysis of prenatal diagnostic specimens. STUDY DESIGN: Prenatal diagnostic specimens were chosen at random for analysis without knowledge of clinical indication. Primed in situ labeling with primers for chromosomes 18, 21, X, and Y was performed separate from conventional cytogenetic analyses. All clinical management considerations were based solely on conventional cytogenetic analyses. RESULTS: Forty-one samples were analyzed by primed in situ labeling: 35 direct preparations of chorionic villi and 6 uncultured amniotic fluid samples. In all cases analysis confirmed the particular chromosome number determined by conventional cytogenetic analysis. CONCLUSIONS: Although conventional metaphase studies remain the standard for prenatal cytogenetic analyses, the preliminary feasibility study finds primed in situ labeling to be a rapid and reliable adjunctive diagnostic technique applicable for prenatal diagnosis in certain clinical situations. Further study is needed to assess the efficacy of primed in situ labeling in comparison to fluorescent in situ hybridization and conventional cytogenetic analyses for prenatal diagnoses.

AB - OBJECTIVE: Our purpose was to assess the feasibility of primed in situ labeling for analysis of prenatal diagnostic specimens. STUDY DESIGN: Prenatal diagnostic specimens were chosen at random for analysis without knowledge of clinical indication. Primed in situ labeling with primers for chromosomes 18, 21, X, and Y was performed separate from conventional cytogenetic analyses. All clinical management considerations were based solely on conventional cytogenetic analyses. RESULTS: Forty-one samples were analyzed by primed in situ labeling: 35 direct preparations of chorionic villi and 6 uncultured amniotic fluid samples. In all cases analysis confirmed the particular chromosome number determined by conventional cytogenetic analysis. CONCLUSIONS: Although conventional metaphase studies remain the standard for prenatal cytogenetic analyses, the preliminary feasibility study finds primed in situ labeling to be a rapid and reliable adjunctive diagnostic technique applicable for prenatal diagnosis in certain clinical situations. Further study is needed to assess the efficacy of primed in situ labeling in comparison to fluorescent in situ hybridization and conventional cytogenetic analyses for prenatal diagnoses.

KW - Cytogenetics

KW - In situ hybridization

KW - Prenatal diagnosis

UR - http://www.scopus.com/inward/record.url?scp=0031799102&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031799102&partnerID=8YFLogxK

U2 - 10.1016/S0002-9378(98)70338-2

DO - 10.1016/S0002-9378(98)70338-2

M3 - Article

C2 - 9662317

AN - SCOPUS:0031799102

VL - 178

SP - 1313

EP - 1320

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 6

ER -